Portfolio (Quarterly)
Guide ↗
SUPERSTRING CAPITAL MANAGEMENT LP
· CIK 0001931118| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ANL | ADLAI NORTYE LTD | Healthcare | 414,852.0 | $2.9M | 2.05% | NEW | — | $6.92 | +67.1% |
| 22 | CABA | CABALETTA BIO INC | Healthcare | 1,066,239.0 | $2.9M | 2.05% | -1.2M | -52.7% | $2.69 | +37.2% |
| 23 | PFE | PFIZER INC | Healthcare | 74,000.0 | $2.1M | 1.49% | NEW | — | $28.08 | -7.6% |
| 24 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 11,217.0 | $1.9M | 1.35% | -26K | -70.0% | $169.02 | +38.2% |
| 25 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 115,234.0 | $1.5M | 1.04% | -140K | -54.9% | $12.67 | -33.2% |
| 26 | ACRS | ACLARIS THERAPEUTICS INC | Healthcare | 366,490.0 | $1.4M | 0.98% | NEW | — | $3.75 | +21.1% |
| 27 | — | CLIMB BIO INC | — | 199,209.0 | $1.4M | 0.97% | NEW | — | $6.85 | — |
| 28 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 258,269.0 | $1.2M | 0.82% | -722K | -73.7% | $4.47 | +22.8% |
| 29 | — | BRIGHT MINDS BIOSCIENCES INC | — | 13,311.0 | $971K | 0.69% | -34K | -71.8% | $72.97 | — |
| 30 | TNXP | TONIX PHARMACEUTICALS HLDG C | Healthcare | 63,540.0 | $874K | 0.62% | NEW | — | $13.75 | +5.5% |
| 31 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 59,484.0 | $845K | 0.60% | NEW | — | $14.21 | -1.6% |
| 32 | TARA | PROTARA THERAPEUTICS INC | Healthcare | 121,457.0 | $633K | 0.45% | -239K | -66.3% | $5.21 | -8.6% |
| 33 | — | PALATIN TECHNOLOGIES INC | — | 35,969.0 | $627K | 0.45% | +2K | +5.9% | $17.42 | — |
| 34 | BMEA | BIOMEA FUSION INC | Healthcare | 250,000.0 | $382K | 0.27% | — | — | $1.53 | -10.5% |
| 35 | IPSC | CENTURY THERAPEUTICS INC | Healthcare | 119,308.0 | $270K | 0.19% | -344K | -74.2% | $2.26 | +0.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%